Cargando…

A Novel Porcine Model of Ischemia-Reperfusion Injury After Cross-Clamping the Thoracic Aorta Revealed Substantial Cardiopulmonary, Thromboinflammatory and Biochemical Changes Without Effect of C1-Inhibitor Treatment

Ischemic injury worsens upon return of blood and innate immunity including the complement system play a central role in ischemia-reperfusion injury (IRI) as in thoracic aortic surgery. Complement component1 inhibitor (C1-INH) has been shown to reduce IRI and is a broad-acting plasma cascade inhibito...

Descripción completa

Detalles Bibliográficos
Autores principales: Nielsen, Erik Waage, Miller, Yoav, Brekke, Ole-Lars, Grond, Joost, Duong, Anh Hoang, Fure, Hilde, Ludviksen, Judith Krey, Pettersen, Kristin, Reubsaet, Leon, Solberg, Rigmor, Johansen, Harald Thidemann, Mollnes, Tom Eirik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9010742/
https://www.ncbi.nlm.nih.gov/pubmed/35432333
http://dx.doi.org/10.3389/fimmu.2022.852119
_version_ 1784687548371566592
author Nielsen, Erik Waage
Miller, Yoav
Brekke, Ole-Lars
Grond, Joost
Duong, Anh Hoang
Fure, Hilde
Ludviksen, Judith Krey
Pettersen, Kristin
Reubsaet, Leon
Solberg, Rigmor
Johansen, Harald Thidemann
Mollnes, Tom Eirik
author_facet Nielsen, Erik Waage
Miller, Yoav
Brekke, Ole-Lars
Grond, Joost
Duong, Anh Hoang
Fure, Hilde
Ludviksen, Judith Krey
Pettersen, Kristin
Reubsaet, Leon
Solberg, Rigmor
Johansen, Harald Thidemann
Mollnes, Tom Eirik
author_sort Nielsen, Erik Waage
collection PubMed
description Ischemic injury worsens upon return of blood and innate immunity including the complement system play a central role in ischemia-reperfusion injury (IRI) as in thoracic aortic surgery. Complement component1 inhibitor (C1-INH) has been shown to reduce IRI and is a broad-acting plasma cascade inhibitor. We established a new porcine model of IRI by cross-clamping the thoracic aorta and evaluated the global changes occurring in organ function, systemic inflammatory response and organ damage with or without treatment with C1-INH-concentrate. Twenty-four piglets (8.8-11.1 kg) underwent 45 minutes clamping of the thoracic aorta at the Th8 level. Upfront 12 piglets received human saline and 12 received C1-INH (250 IU/kg) intravenously. Three sham animals received thoracic opening without clamping. Reperfusion lasted 5 hours. We studied ten cardiorespiratory markers, three hematologic markers, eleven inflammatory markers, and twelve organ damage markers over the whole experimental period. Postmortem tissue homogenates from seven organs were examined for inflammatory markers and analysed by two-way repeated-measures ANOVA, area under the curve or unpaired t-tests. By excluding sham and combining treated and untreated animals, the markers reflected a uniform, broad and severe organ dysfunction. The mean and range fold change from before cross-clamp onset to maximum change for the different groups of markers were: cardiorespiratory 1.4 (0.2-3.7), hematologic 1.9 (1.2-2.7), plasma inflammatory 19.5 (1.4-176) and plasma organ damage 2.9 (1.1-8.6). Treatment with C1-INH had only a marginal effect on the IRI-induced changes, reaching statistical significance only for the plasma complement activation product TCC (p=0.0083) and IL-4 (p=0.022) and INF-α (p=0.016) in the colon tissue. In conclusion, the present novel model of porcine global IRI is forceful with regards to central markers and could generally be applicable for pathophysiological studies. C1-INH treatment had no significant effect, but the model allows for future testing of other drugs attenuating IRI globally.
format Online
Article
Text
id pubmed-9010742
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-90107422022-04-16 A Novel Porcine Model of Ischemia-Reperfusion Injury After Cross-Clamping the Thoracic Aorta Revealed Substantial Cardiopulmonary, Thromboinflammatory and Biochemical Changes Without Effect of C1-Inhibitor Treatment Nielsen, Erik Waage Miller, Yoav Brekke, Ole-Lars Grond, Joost Duong, Anh Hoang Fure, Hilde Ludviksen, Judith Krey Pettersen, Kristin Reubsaet, Leon Solberg, Rigmor Johansen, Harald Thidemann Mollnes, Tom Eirik Front Immunol Immunology Ischemic injury worsens upon return of blood and innate immunity including the complement system play a central role in ischemia-reperfusion injury (IRI) as in thoracic aortic surgery. Complement component1 inhibitor (C1-INH) has been shown to reduce IRI and is a broad-acting plasma cascade inhibitor. We established a new porcine model of IRI by cross-clamping the thoracic aorta and evaluated the global changes occurring in organ function, systemic inflammatory response and organ damage with or without treatment with C1-INH-concentrate. Twenty-four piglets (8.8-11.1 kg) underwent 45 minutes clamping of the thoracic aorta at the Th8 level. Upfront 12 piglets received human saline and 12 received C1-INH (250 IU/kg) intravenously. Three sham animals received thoracic opening without clamping. Reperfusion lasted 5 hours. We studied ten cardiorespiratory markers, three hematologic markers, eleven inflammatory markers, and twelve organ damage markers over the whole experimental period. Postmortem tissue homogenates from seven organs were examined for inflammatory markers and analysed by two-way repeated-measures ANOVA, area under the curve or unpaired t-tests. By excluding sham and combining treated and untreated animals, the markers reflected a uniform, broad and severe organ dysfunction. The mean and range fold change from before cross-clamp onset to maximum change for the different groups of markers were: cardiorespiratory 1.4 (0.2-3.7), hematologic 1.9 (1.2-2.7), plasma inflammatory 19.5 (1.4-176) and plasma organ damage 2.9 (1.1-8.6). Treatment with C1-INH had only a marginal effect on the IRI-induced changes, reaching statistical significance only for the plasma complement activation product TCC (p=0.0083) and IL-4 (p=0.022) and INF-α (p=0.016) in the colon tissue. In conclusion, the present novel model of porcine global IRI is forceful with regards to central markers and could generally be applicable for pathophysiological studies. C1-INH treatment had no significant effect, but the model allows for future testing of other drugs attenuating IRI globally. Frontiers Media S.A. 2022-04-01 /pmc/articles/PMC9010742/ /pubmed/35432333 http://dx.doi.org/10.3389/fimmu.2022.852119 Text en Copyright © 2022 Nielsen, Miller, Brekke, Grond, Duong, Fure, Ludviksen, Pettersen, Reubsaet, Solberg, Johansen and Mollnes https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Nielsen, Erik Waage
Miller, Yoav
Brekke, Ole-Lars
Grond, Joost
Duong, Anh Hoang
Fure, Hilde
Ludviksen, Judith Krey
Pettersen, Kristin
Reubsaet, Leon
Solberg, Rigmor
Johansen, Harald Thidemann
Mollnes, Tom Eirik
A Novel Porcine Model of Ischemia-Reperfusion Injury After Cross-Clamping the Thoracic Aorta Revealed Substantial Cardiopulmonary, Thromboinflammatory and Biochemical Changes Without Effect of C1-Inhibitor Treatment
title A Novel Porcine Model of Ischemia-Reperfusion Injury After Cross-Clamping the Thoracic Aorta Revealed Substantial Cardiopulmonary, Thromboinflammatory and Biochemical Changes Without Effect of C1-Inhibitor Treatment
title_full A Novel Porcine Model of Ischemia-Reperfusion Injury After Cross-Clamping the Thoracic Aorta Revealed Substantial Cardiopulmonary, Thromboinflammatory and Biochemical Changes Without Effect of C1-Inhibitor Treatment
title_fullStr A Novel Porcine Model of Ischemia-Reperfusion Injury After Cross-Clamping the Thoracic Aorta Revealed Substantial Cardiopulmonary, Thromboinflammatory and Biochemical Changes Without Effect of C1-Inhibitor Treatment
title_full_unstemmed A Novel Porcine Model of Ischemia-Reperfusion Injury After Cross-Clamping the Thoracic Aorta Revealed Substantial Cardiopulmonary, Thromboinflammatory and Biochemical Changes Without Effect of C1-Inhibitor Treatment
title_short A Novel Porcine Model of Ischemia-Reperfusion Injury After Cross-Clamping the Thoracic Aorta Revealed Substantial Cardiopulmonary, Thromboinflammatory and Biochemical Changes Without Effect of C1-Inhibitor Treatment
title_sort novel porcine model of ischemia-reperfusion injury after cross-clamping the thoracic aorta revealed substantial cardiopulmonary, thromboinflammatory and biochemical changes without effect of c1-inhibitor treatment
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9010742/
https://www.ncbi.nlm.nih.gov/pubmed/35432333
http://dx.doi.org/10.3389/fimmu.2022.852119
work_keys_str_mv AT nielsenerikwaage anovelporcinemodelofischemiareperfusioninjuryaftercrossclampingthethoracicaortarevealedsubstantialcardiopulmonarythromboinflammatoryandbiochemicalchangeswithouteffectofc1inhibitortreatment
AT milleryoav anovelporcinemodelofischemiareperfusioninjuryaftercrossclampingthethoracicaortarevealedsubstantialcardiopulmonarythromboinflammatoryandbiochemicalchangeswithouteffectofc1inhibitortreatment
AT brekkeolelars anovelporcinemodelofischemiareperfusioninjuryaftercrossclampingthethoracicaortarevealedsubstantialcardiopulmonarythromboinflammatoryandbiochemicalchangeswithouteffectofc1inhibitortreatment
AT grondjoost anovelporcinemodelofischemiareperfusioninjuryaftercrossclampingthethoracicaortarevealedsubstantialcardiopulmonarythromboinflammatoryandbiochemicalchangeswithouteffectofc1inhibitortreatment
AT duonganhhoang anovelporcinemodelofischemiareperfusioninjuryaftercrossclampingthethoracicaortarevealedsubstantialcardiopulmonarythromboinflammatoryandbiochemicalchangeswithouteffectofc1inhibitortreatment
AT furehilde anovelporcinemodelofischemiareperfusioninjuryaftercrossclampingthethoracicaortarevealedsubstantialcardiopulmonarythromboinflammatoryandbiochemicalchangeswithouteffectofc1inhibitortreatment
AT ludviksenjudithkrey anovelporcinemodelofischemiareperfusioninjuryaftercrossclampingthethoracicaortarevealedsubstantialcardiopulmonarythromboinflammatoryandbiochemicalchangeswithouteffectofc1inhibitortreatment
AT pettersenkristin anovelporcinemodelofischemiareperfusioninjuryaftercrossclampingthethoracicaortarevealedsubstantialcardiopulmonarythromboinflammatoryandbiochemicalchangeswithouteffectofc1inhibitortreatment
AT reubsaetleon anovelporcinemodelofischemiareperfusioninjuryaftercrossclampingthethoracicaortarevealedsubstantialcardiopulmonarythromboinflammatoryandbiochemicalchangeswithouteffectofc1inhibitortreatment
AT solbergrigmor anovelporcinemodelofischemiareperfusioninjuryaftercrossclampingthethoracicaortarevealedsubstantialcardiopulmonarythromboinflammatoryandbiochemicalchangeswithouteffectofc1inhibitortreatment
AT johansenharaldthidemann anovelporcinemodelofischemiareperfusioninjuryaftercrossclampingthethoracicaortarevealedsubstantialcardiopulmonarythromboinflammatoryandbiochemicalchangeswithouteffectofc1inhibitortreatment
AT mollnestomeirik anovelporcinemodelofischemiareperfusioninjuryaftercrossclampingthethoracicaortarevealedsubstantialcardiopulmonarythromboinflammatoryandbiochemicalchangeswithouteffectofc1inhibitortreatment
AT nielsenerikwaage novelporcinemodelofischemiareperfusioninjuryaftercrossclampingthethoracicaortarevealedsubstantialcardiopulmonarythromboinflammatoryandbiochemicalchangeswithouteffectofc1inhibitortreatment
AT milleryoav novelporcinemodelofischemiareperfusioninjuryaftercrossclampingthethoracicaortarevealedsubstantialcardiopulmonarythromboinflammatoryandbiochemicalchangeswithouteffectofc1inhibitortreatment
AT brekkeolelars novelporcinemodelofischemiareperfusioninjuryaftercrossclampingthethoracicaortarevealedsubstantialcardiopulmonarythromboinflammatoryandbiochemicalchangeswithouteffectofc1inhibitortreatment
AT grondjoost novelporcinemodelofischemiareperfusioninjuryaftercrossclampingthethoracicaortarevealedsubstantialcardiopulmonarythromboinflammatoryandbiochemicalchangeswithouteffectofc1inhibitortreatment
AT duonganhhoang novelporcinemodelofischemiareperfusioninjuryaftercrossclampingthethoracicaortarevealedsubstantialcardiopulmonarythromboinflammatoryandbiochemicalchangeswithouteffectofc1inhibitortreatment
AT furehilde novelporcinemodelofischemiareperfusioninjuryaftercrossclampingthethoracicaortarevealedsubstantialcardiopulmonarythromboinflammatoryandbiochemicalchangeswithouteffectofc1inhibitortreatment
AT ludviksenjudithkrey novelporcinemodelofischemiareperfusioninjuryaftercrossclampingthethoracicaortarevealedsubstantialcardiopulmonarythromboinflammatoryandbiochemicalchangeswithouteffectofc1inhibitortreatment
AT pettersenkristin novelporcinemodelofischemiareperfusioninjuryaftercrossclampingthethoracicaortarevealedsubstantialcardiopulmonarythromboinflammatoryandbiochemicalchangeswithouteffectofc1inhibitortreatment
AT reubsaetleon novelporcinemodelofischemiareperfusioninjuryaftercrossclampingthethoracicaortarevealedsubstantialcardiopulmonarythromboinflammatoryandbiochemicalchangeswithouteffectofc1inhibitortreatment
AT solbergrigmor novelporcinemodelofischemiareperfusioninjuryaftercrossclampingthethoracicaortarevealedsubstantialcardiopulmonarythromboinflammatoryandbiochemicalchangeswithouteffectofc1inhibitortreatment
AT johansenharaldthidemann novelporcinemodelofischemiareperfusioninjuryaftercrossclampingthethoracicaortarevealedsubstantialcardiopulmonarythromboinflammatoryandbiochemicalchangeswithouteffectofc1inhibitortreatment
AT mollnestomeirik novelporcinemodelofischemiareperfusioninjuryaftercrossclampingthethoracicaortarevealedsubstantialcardiopulmonarythromboinflammatoryandbiochemicalchangeswithouteffectofc1inhibitortreatment